Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -13.05%37.72M | -5.53%38.92M | 1.10%41.3M | -4.19%174.31M | -4.01%48.89M | -12.44%43.38M | -7.94%41.2M | 11.28%40.85M | 5.67%181.93M | 20.05%50.93M |
| Operating revenue | -13.05%37.72M | -5.53%38.92M | 1.10%41.3M | -4.19%174.31M | -4.01%48.89M | -12.44%43.38M | -7.94%41.2M | 11.28%40.85M | 5.67%181.93M | 20.05%50.93M |
| Cost of revenue | -1.18%26.25M | 8.82%28.1M | 2.11%26.75M | -10.17%109.94M | -1.09%31.35M | -18.20%26.56M | -14.47%25.83M | -6.52%26.2M | -15.01%122.39M | 2.78%31.7M |
| Gross profit | -31.80%11.47M | -29.64%10.82M | -0.72%14.54M | 8.12%64.38M | -8.83%17.54M | -1.48%16.81M | 5.62%15.38M | 68.72%14.65M | 111.44%59.54M | 66.00%19.24M |
| Operating expense | -16.35%12.57M | 5.83%14.98M | 3.29%14.65M | -8.78%58.51M | -7.62%15.13M | 0.93%15.03M | -7.37%14.16M | -19.30%14.19M | -2.79%64.14M | 11.98%16.38M |
| Selling and administrative expenses | -15.69%9.97M | 6.89%11.63M | 2.11%11.4M | -6.89%45.81M | -3.26%11.95M | -0.66%11.82M | -15.03%10.88M | -8.09%11.16M | -13.22%49.2M | 16.09%12.35M |
| -Selling and marketing expense | -7.49%4.8M | -12.69%5.29M | -12.55%5.18M | -9.10%22.94M | -16.73%5.77M | -15.87%5.18M | -8.51%6.06M | 7.34%5.92M | -6.36%25.24M | 18.39%6.93M |
| -General and administrative expense | -22.09%5.17M | 31.53%6.34M | 18.66%6.22M | -4.56%22.87M | 13.98%6.17M | 15.67%6.64M | -22.03%4.82M | -20.94%5.24M | -19.43%23.96M | 13.26%5.42M |
| Research and development costs | -37.79%805K | 3.06%1.48M | -1.84%1.23M | -9.59%5.26M | -27.42%1.28M | 4.44%1.29M | 12.45%1.44M | -18.71%1.25M | -22.96%5.82M | -4.13%1.77M |
| Other operating expenses | -5.95%1.8M | 1.68%1.87M | 14.37%2.03M | -18.44%7.44M | -15.92%1.91M | 9.30%1.92M | 53.16%1.84M | -54.46%1.78M | 426.26%9.12M | 5.44%2.27M |
| Operating profit | -161.94%-1.11M | -441.87%-4.16M | -124.30%-112K | 227.75%5.87M | -15.79%2.41M | -17.98%1.78M | 267.54%1.22M | 105.18%461K | 87.85%-4.59M | 193.98%2.86M |
| Net non-operating interest income (expenses) | 79.81%-239K | 45.36%-253K | 66.55%-189K | 45.73%-2.41M | 81.72%-196K | -14.40%-1.18M | 58.92%-463K | 53.03%-565K | 13.15%-4.44M | 12.42%-1.07M |
| Non-operating interest income | -33.72%226K | -51.87%232K | -46.42%262K | 223.88%1.59M | 25.57%275K | 111.80%341K | 354.72%482K | 12,125.00%489K | 860.78%490K | 21,800.00%219K |
| Non-operating interest expense | -69.51%465K | -48.68%485K | -57.21%451K | -18.92%4M | -63.52%471K | 27.51%1.53M | -23.36%945K | -12.68%1.05M | -4.52%4.93M | 5.39%1.29M |
| Other net income (expenses) | -130.44%-1.98M | -1,432.69%-2.08M | -109.90%-315K | 325.19%11.76M | 482.53%1.91M | 187.42%6.51M | -96.16%156K | 338.89%3.18M | 56.55%-5.22M | 68.97%-498K |
| Gain on sale of security | 267.22%602K | -634.08%-1.91M | -112.19%-112K | 575.08%2.97M | 462.79%2.06M | -143.80%-360K | 157.74%358K | 452.11%919K | -143.32%-626K | -33.41%-567K |
| Special income (charges) | -137.61%-2.59M | 17.33%-167K | -108.97%-203K | 291.14%8.78M | -320.29%-152K | 183.09%6.87M | -104.32%-202K | 311.30%2.26M | 65.86%-4.6M | 105.85%69K |
| -Less:Restructuring and mergern&acquisition | 329.30%2.59M | -13.86%174K | 52.17%210K | -63.01%1.11M | 11.18%169K | 88.16%604K | -86.21%202K | -87.11%138K | -77.65%3.01M | -87.12%152K |
| -Less:Impairment of capital assets | --0 | --0 | --0 | -93.92%530K | --0 | --0 | --0 | --530K | --8.72M | --764K |
| -Less:Other special charges | 99.89%-8K | ---7K | 99.76%-7K | ---10.43M | ---17K | ---7.48M | ---- | ---2.93M | ---- | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | --0 | --0 | --0 | --0 | ---- | --7.13M | --985K |
| Income before tax | -146.77%-3.33M | -813.06%-6.5M | -120.01%-616K | 206.78%15.22M | 219.74%4.12M | 212.72%7.11M | -58.70%911K | 126.92%3.08M | 74.06%-14.25M | 121.93%1.29M |
| Income tax | 582.61%157K | -66.35%106K | 36.36%45K | 34.94%448K | -76.81%77K | 23K | 315K | 33K | 1,480.95%332K | 797.30%332K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -149.13%-3.48M | -1,207.72%-6.6M | -121.71%-661K | 201.28%14.77M | 322.83%4.04M | 212.36%7.09M | -72.98%596K | 126.63%3.05M | 73.47%-14.58M | 116.17%955K |
| Net income continuous operations | -149.13%-3.48M | -1,207.72%-6.6M | -121.71%-661K | 201.28%14.77M | 322.83%4.04M | 212.36%7.09M | -72.98%596K | 126.63%3.05M | 73.47%-14.58M | 116.17%955K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -149.13%-3.48M | -1,207.72%-6.6M | -121.71%-661K | 201.28%14.77M | 322.83%4.04M | 212.36%7.09M | -72.98%596K | 126.63%3.05M | 73.47%-14.58M | 116.17%955K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -149.13%-3.48M | -1,207.72%-6.6M | -121.71%-661K | 201.28%14.77M | 322.83%4.04M | 212.36%7.09M | -72.98%596K | 126.63%3.05M | 73.47%-14.58M | 116.17%955K |
| Diluted earnings per share | -150.00%-0.02 | -0.03 | 0 | 161.54%0.08 | 100.00%0.02 | 180.00%0.04 | 0 | 120.00%0.02 | 76.36%-0.13 | 118.98%0.01 |
| Basic earnings per share | -166.67%-0.02 | -0.03 | 0 | 153.85%0.07 | 100.00%0.02 | 160.00%0.03 | 0 | 110.00%0.01 | 76.36%-0.13 | 118.98%0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.